FIG 3.

Patients with NET with CH were more likely to be thrombocytopenic during PRRT. (A) State space and transition counts for thrombocytopenia depict patient transitions from normal platelet count (health) to any grade of thrombocytopenia or death. (B) Aalen-Johansen plot showing that patients with CH (VAF ≥2%) were more likely to experience thrombocytopenia and remain thrombocytopenic longer than patients without CH. (C) On average, patients with CH spent about 200 days (95% CI, 88.3 to 312.4) being thrombocytopenic compared with 99 days (95% CI, 45.3 to 153.3) without. Green represents healthy, orange represents thrombocytopenia, and gray represents death. CH, clonal hematopoiesis.